These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 25691453

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies.
    Kimura T, Aikata H, Doi Y, Imano N, Takeuchi Y, Takahashi I, Nishibuchi I, Katsuta T, Kenjo M, Murakami Y, Awai K, Chayama K, Nagata Y.
    Technol Cancer Res Treat; 2018 Jan 01; 17():1533033818783450. PubMed ID: 29963972
    [Abstract] [Full Text] [Related]

  • 25. Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4-B1: a pilot study.
    Wang F, Numata K, Takeda A, Ogushi K, Fukuda H, Nihonmatsu H, Hara K, Chuma M, Tsurugai Y, Maeda S.
    BMC Cancer; 2021 Oct 30; 21(1):1169. PubMed ID: 34717577
    [Abstract] [Full Text] [Related]

  • 26. SBRT for Hepatocellular Carcinoma: 8-Year Experience from a Regional Transplant Center.
    Qiu H, Moravan MJ, Milano MT, Usuki KY, Katz AW.
    J Gastrointest Cancer; 2018 Dec 30; 49(4):463-469. PubMed ID: 28710606
    [Abstract] [Full Text] [Related]

  • 27. A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy.
    Jang WI, Bae SH, Kim MS, Han CJ, Park SC, Kim SB, Cho EH, Choi CW, Kim KS, Hwang S, Kim JH, Chang AR, Park Y, Kim ES, Kim WC, Jo S, Park HJ.
    Cancer; 2020 Jan 15; 126(2):363-372. PubMed ID: 31747476
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular Carcinoma.
    Shen PC, Chang WC, Lo CH, Yang JF, Lee MS, Dai YH, Lin CS, Fan CY, Huang WY.
    Int J Radiat Oncol Biol Phys; 2019 Oct 01; 105(2):307-318. PubMed ID: 31175903
    [Abstract] [Full Text] [Related]

  • 31. Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.
    Moore A, Cohen-Naftaly M, Tobar A, Kundel Y, Benjaminov O, Braun M, Issachar A, Mor E, Sarfaty M, Bragilovski D, Hur RB, Gordon N, Stemmer SM, Allen AM.
    Radiat Oncol; 2017 Oct 19; 12(1):163. PubMed ID: 29052532
    [Abstract] [Full Text] [Related]

  • 32. Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma.
    Gkika E, Schultheiss M, Bettinger D, Maruschke L, Neeff HP, Schulenburg M, Adebahr S, Kirste S, Nestle U, Thimme R, Grosu AL, Brunner TB.
    Radiat Oncol; 2017 Jul 12; 12(1):116. PubMed ID: 28701219
    [Abstract] [Full Text] [Related]

  • 33. Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting.
    Gerum S, Heinz C, Belka C, Walter F, Paprottka PM, De Toni EN, Roeder F.
    Strahlenther Onkol; 2020 Apr 12; 196(4):334-348. PubMed ID: 31732784
    [Abstract] [Full Text] [Related]

  • 34. Effectiveness of stereotactic body radiotherapy for portal vein tumor thrombosis in patients with hepatocellular carcinoma and underlying chronic liver disease.
    Choi HS, Kang KM, Jeong BK, Jeong H, Lee YH, Ha IB, Song JH.
    Asia Pac J Clin Oncol; 2021 Jun 12; 17(3):209-215. PubMed ID: 32757461
    [Abstract] [Full Text] [Related]

  • 35. Stereotactic body radiotherapy versus hepatic resection for hepatocellular carcinoma (≤ 5 cm): a propensity score analysis.
    Sun J, Wang Q, Hong ZX, Li WG, He WP, Zhang T, Zhang AM, Fan YZ, Sun YZ, Zheng L, Duan XZ.
    Hepatol Int; 2020 Sep 12; 14(5):788-797. PubMed ID: 32886334
    [Abstract] [Full Text] [Related]

  • 36. Combined stereotactic body radiotherapy and trans-arterial chemoembolization as initial treatment in BCLC stage B-C hepatocellular carcinoma.
    Chiang CL, Chan MKH, Yeung CSY, Ho CHM, Lee FAS, Lee VWY, Wong FCS, Blanck O.
    Strahlenther Onkol; 2019 Mar 12; 195(3):254-264. PubMed ID: 30413833
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
    Long Y, Liang Y, Li S, Guo J, Wang Y, Luo Y, Wu Y.
    Radiat Oncol; 2021 Apr 08; 16(1):68. PubMed ID: 33832536
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.